Patient Guide: A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 136 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04923893
Status: ACTIVE_NOT_RECRUITING
Condition: Multiple Myeloma
Phase: PHASE3

Find a Study Location Near You

This study is available at 136 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • San Francisco, California
  • New Haven, Connecticut
  • Miami, Florida
  • • And 133 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily